November - December, 2020
Key Highlights
• Advancements on the COVID-19 vaccine will heavily boost recovery in 2021.
• Saving rates and a normalisation of the investiment spending drive growth.
• Economy and markets are and will be supported by monetary policies.
• Preference for mid and small caps.
• Preference for cyclical and quality value stocks.
• Stimulus in the eurozone will keep supporting the market.
• Faster recovery in the US and China compared to the Eurozone.
• Swiss equities downgraded because of low probability of earning surprises.